InflaRx N.V. (IFRX)

USD 1.73

(-6.49%)

Total Debt Summary of InflaRx N.V.

  • InflaRx N.V.'s latest annual total debt in 2023 was 1.12 Million EUR , down -17.37% from previous year.
  • InflaRx N.V.'s latest quarterly total debt in 2024 Q2 was 999.25 Thousand EUR , down -9.72% from previous quarter.
  • InflaRx N.V. reported annual total debt of 1.35 Million EUR in 2022, down -5.29% from previous year.
  • InflaRx N.V. reported annual total debt of 1.43 Million EUR in 2021, up 156.25% from previous year.
  • InflaRx N.V. reported quarterly total debt of 1.1 Million EUR for 2024 Q1, down -1.32% from previous quarter.
  • InflaRx N.V. reported quarterly total debt of 1.26 Million EUR for 2023 Q1, down -6.99% from previous quarter.

Annual Total Debt Chart of InflaRx N.V. (2023 - 2015)

Historical Annual Total Debt of InflaRx N.V. (2023 - 2015)

Year Total Debt Total Debt Growth
2023 1.12 Million EUR -17.37%
2022 1.35 Million EUR -5.29%
2021 1.43 Million EUR 156.25%
2020 559.04 Thousand EUR -33.92%
2019 845.94 Thousand EUR 0.0%
2018 - EUR 0.0%
2017 - EUR -100.0%
2016 53.44 Million EUR 157.62%
2015 20.74 Million EUR 0.0%

Peer Total Debt Comparison of InflaRx N.V.

Name Total Debt Total Debt Difference
NeuroSense Therapeutics Ltd. 142 Thousand USD -689.414%
Psyence Biomedical Ltd. 7.65 Million USD 85.361%
XOMA Corporation 124.45 Million USD 99.099%
Mesoblast Limited 118.92 Million USD 99.057%
Xeris Biopharma Holdings, Inc. 229.19 Million USD 99.511%
Aptorum Group Limited 3.36 Million USD 66.662%
Qualigen Therapeutics, Inc. 1.29 Million USD 13.72%
HilleVax, Inc. 51.19 Million USD 97.81%
Rocket Pharmaceuticals, Inc. 25.04 Million USD 95.524%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD 94.632%
Precision BioSciences, Inc. 31.26 Million USD 96.415%
Dyadic International, Inc. 136.92 Thousand USD -718.649%
Intensity Therapeutics, Inc. 158 Thousand USD -609.473%
IDEAYA Biosciences, Inc. 2.87 Million USD 60.969%
Eton Pharmaceuticals, Inc. 5.45 Million USD 79.451%
VYNE Therapeutics Inc. 214 Thousand USD -423.817%
EyePoint Pharmaceuticals, Inc. 5.46 Million USD 79.503%
Adaptive Biotechnologies Corporation 229.43 Million USD 99.511%
Tenaya Therapeutics, Inc. 12.42 Million USD 90.977%
IGM Biosciences, Inc. 40.5 Million USD 97.233%
Opthea Limited 200.62 Million USD 99.441%
Milestone Pharmaceuticals Inc. 51.77 Million USD 97.835%
Abeona Therapeutics Inc. 5.4 Million USD 79.241%
Tonix Pharmaceuticals Holding Corp. 9.81 Million USD 88.577%
Ligand Pharmaceuticals Incorporated 6.16 Million USD 81.817%
NextCure, Inc. 6.6 Million USD 83.028%
Inhibikase Therapeutics, Inc. 622 Thousand USD -80.219%
Ovid Therapeutics Inc. 46 Million USD 97.563%
CASI Pharmaceuticals, Inc. 21.23 Million USD 94.722%
Arcturus Therapeutics Holdings Inc. 30.21 Million USD 96.29%
Syros Pharmaceuticals, Inc. 62.07 Million USD 98.194%
Senti Biosciences, Inc. 37.66 Million USD 97.024%
Apollomics, Inc. 4.66 Million USD 75.95%
PureTech Health plc 25.51 Million USD 95.606%
Oncternal Therapeutics, Inc. 318 Thousand USD -252.506%
Barinthus Biotherapeutics plc 12.97 Million USD 91.361%
Kymera Therapeutics, Inc. 84.67 Million USD 98.676%
ChromaDex Corporation 3.27 Million USD 65.793%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 104.18 Million USD 98.924%
Sangamo Therapeutics, Inc. 38.1 Million USD 97.058%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 104.77 Million USD 98.93%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 103.53 Million USD 98.917%
BioXcel Therapeutics, Inc. 101.38 Million USD 98.894%
Fortress Biotech, Inc. 88.59 Million USD 98.735%
Checkpoint Therapeutics, Inc. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 63.16 Million USD 98.225%
Celcuity Inc. 37.44 Million USD 97.006%
ContextLogic Inc. 6 Million USD 81.317%
GH Research PLC 343 Thousand USD -226.813%
HOOKIPA Pharma Inc. 6.55 Million USD 82.909%
Cassava Sciences, Inc. - USD -Infinity%
Cyclacel Pharmaceuticals, Inc. 37 Thousand USD -2929.643%
ImmuCell Corporation 11.96 Million USD 90.635%
Amarin Corporation plc 8.73 Million USD 87.17%
TG Therapeutics, Inc. 110.79 Million USD 98.988%
X4 Pharmaceuticals, Inc. 58.28 Million USD 98.077%
Acelyrin, Inc. 1.19 Million USD 6.117%
BriaCell Therapeutics Corp. - USD -Infinity%
Seer, Inc. 28.25 Million USD 96.033%
Novavax, Inc. 280.63 Million USD 99.601%
Phathom Pharmaceuticals, Inc. 139.03 Million USD 99.194%
Jazz Pharmaceuticals plc 5.79 Billion USD 99.981%
AnaptysBio, Inc. 17.81 Million USD 93.707%
Aptevo Therapeutics Inc. 5.39 Million USD 79.23%
PMV Pharmaceuticals, Inc. 13.28 Million USD 91.563%
AbCellera Biologics Inc. 77.38 Million USD 98.551%
CorMedix Inc. 667.63 Thousand USD -67.902%
Cartesian Therapeutics, Inc. 10.95 Million USD 89.768%
Marker Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 99.959%
Aptose Biosciences Inc. 1 Million USD -11.008%
ZyVersa Therapeutics, Inc. 8656.00 USD -12850.185%
Soligenix, Inc. 3.49 Million USD 67.922%
Century Therapeutics, Inc. 48.17 Million USD 97.673%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 99.027%
TransCode Therapeutics, Inc. 450.57 Thousand USD -148.788%
Kura Oncology, Inc. 17.2 Million USD 93.483%
RAPT Therapeutics, Inc. 6.9 Million USD 83.768%
Ardelyx, Inc. 55.98 Million USD 97.998%
Ainos, Inc. 5.96 Million USD 81.203%
TScan Therapeutics, Inc. 92.43 Million USD 98.787%
Ocean Biomedical, Inc. 2.15 Million USD 47.862%
Prothena Corporation plc 11.83 Million USD 90.528%
CytomX Therapeutics, Inc. 13.97 Million USD 91.978%
Autolus Therapeutics plc 52.96 Million USD 97.884%
Mineralys Therapeutics, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 25.23 Million USD 95.558%
Eterna Therapeutics Inc. 41.84 Million USD 97.321%
Celularity Inc. 65.41 Million USD 98.286%
Rallybio Corporation 392 Thousand USD -185.961%
GRI Bio, Inc. 14 Thousand USD -7906.914%
Xenetic Biosciences, Inc. - USD -Infinity%
Omeros Corporation 338.28 Million USD 99.669%
INmune Bio, Inc. 10.43 Million USD 89.26%
Heron Therapeutics, Inc. 179.62 Million USD 99.376%
SAB Biotherapeutics, Inc. 5.9 Million USD 81.023%
Pasithea Therapeutics Corp. 81.68 Thousand USD -1272.39%
Entero Therapeutics, Inc. 826.84 Thousand USD -35.572%
Humacyte, Inc. 58.1 Million USD 98.071%
Atara Biotherapeutics, Inc. 57.87 Million USD 98.063%
Coherus BioSciences, Inc. 480.84 Million USD 99.767%
Immunocore Holdings plc 84.03 Million USD 98.666%
Cocrystal Pharma, Inc. 1.85 Million USD 39.505%
Verastem, Inc. 41.55 Million USD 97.303%
Pliant Therapeutics, Inc. 11.37 Million USD 90.143%
Histogen Inc. 4.62 Million USD 75.747%
Surrozen, Inc. 3.37 Million USD 66.825%
Blueprint Medicines Corporation 774.12 Million USD 99.855%
Organovo Holdings, Inc. 1.39 Million USD 19.586%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
IO Biotech, Inc. 2.49 Million USD 55.053%
MEI Pharma, Inc. - USD -Infinity%
GT Biopharma, Inc. 58 Thousand USD -1832.703%
Centessa Pharmaceuticals plc 84.58 Million USD 98.675%
Hepion Pharmaceuticals, Inc. 209.02 Thousand USD -436.297%
Cabaletta Bio, Inc. 5.01 Million USD 77.661%
Summit Therapeutics Inc. 106.09 Million USD 98.943%
Alaunos Therapeutics, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 110.35 Million USD 98.984%
BioRestorative Therapies, Inc. 162.31 Thousand USD -590.604%
Turnstone Biologics Corp. 3.21 Million USD 65.122%
Pulmatrix, Inc. 8.75 Million USD 87.198%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd 247 Thousand USD -353.833%
Aurinia Pharmaceuticals Inc. 97.6 Million USD 98.852%
Vigil Neuroscience, Inc. 13.85 Million USD 91.906%
Intellia Therapeutics, Inc. 115.34 Million USD 99.028%
Cytokinetics, Incorporated 755.77 Million USD 99.852%
Exelixis, Inc. 189.94 Million USD 99.41%
Nurix Therapeutics, Inc. 30.61 Million USD 96.338%
Apellis Pharmaceuticals, Inc. 110.92 Million USD 98.989%
Evogene Ltd. 1.13 Million USD 1.497%
Replimune Group, Inc. 75.86 Million USD 98.522%
PDS Biotechnology Corporation 23.85 Million USD 95.3%
Hoth Therapeutics, Inc. 55.16 Thousand USD -1932.028%
Jasper Therapeutics, Inc. 2.78 Million USD 59.764%
ESSA Pharma Inc. 80.32 Thousand USD -1295.488%
TNF Pharmaceuticals, Inc. 48.87 Thousand USD -2193.775%
BioLineRx Ltd. 11.59 Million USD 90.329%
Avid Bioservices, Inc. 207.83 Million USD 99.461%
Insmed Incorporated 1.2 Billion USD 99.907%
VistaGen Therapeutics, Inc. 2.12 Million USD 47.124%
Zentalis Pharmaceuticals, Inc. 45.77 Million USD 97.551%
Sagimet Biosciences Inc. 65 Thousand USD -1624.566%
MediWound Ltd. 6.71 Million USD 83.297%
MiMedx Group, Inc. 48.09 Million USD 97.669%
OmniAb, Inc. 25.56 Million USD 95.615%
Alector, Inc. 38.91 Million USD 97.12%
Seres Therapeutics, Inc. 213.93 Million USD 99.476%
PTC Therapeutics, Inc. 415.02 Million USD 99.73%
Mereo BioPharma Group plc 5.95 Million USD 81.167%
Zai Lab Limited 15.15 Million USD 92.601%
Revance Therapeutics, Inc. 478.43 Million USD 99.766%
Syndax Pharmaceuticals, Inc. 1.63 Million USD 31.439%
Aura Biosciences, Inc. 19.55 Million USD 94.268%
Immunic, Inc. 1.33 Million USD 15.969%
Dyne Therapeutics, Inc. 27.41 Million USD 95.911%
Tarsus Pharmaceuticals, Inc. 31.73 Million USD 96.467%
Veracyte, Inc. 12.63 Million USD 91.125%
InMed Pharmaceuticals Inc. 644.86 Million USD 99.826%
FibroGen, Inc. 170.45 Million USD 99.342%
SeaStar Medical Holding Corporation 9.08 Million USD 87.656%
Allakos Inc. 41.46 Million USD 97.297%
scPharmaceuticals Inc. 40.26 Million USD 97.216%
Fulcrum Therapeutics, Inc. 10.82 Million USD 89.641%
Corcept Therapeutics Incorporated 151 Thousand USD -642.363%
Adial Pharmaceuticals, Inc. - USD -Infinity%
NLS Pharmaceutics AG 1.63 Million USD 31.387%
Sonnet BioTherapeutics Holdings, Inc. 203.91 Thousand USD -449.734%
Amylyx Pharmaceuticals, Inc. 4.23 Million USD 73.543%
Precigen, Inc. 7.09 Million USD 84.205%
Fortrea Holdings Inc. 1.67 Billion USD 99.933%
KalVista Pharmaceuticals, Inc. 7.31 Million USD 84.68%
Incyte Corporation 38.28 Million USD 97.072%
Alzamend Neuro, Inc. 300.71 Thousand USD -272.769%
Cara Therapeutics, Inc. 43.16 Million USD 97.403%
XBiotech Inc. - USD -Infinity%
Aligos Therapeutics, Inc. 11.13 Million USD 89.936%
Jasper Therapeutics, Inc. 2.78 Million USD 59.764%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 238.63 Million USD 99.53%
Akero Therapeutics, Inc. 26.04 Million USD 95.696%
Eliem Therapeutics, Inc. 349 Thousand USD -221.194%
Lyra Therapeutics, Inc. 26.88 Million USD 95.83%
Foghorn Therapeutics Inc. 45.07 Million USD 97.513%
Agenus Inc. 350.24 Million USD 99.68%
Kiora Pharmaceuticals, Inc. 106.89 Thousand USD -948.702%
Y-mAbs Therapeutics, Inc. 1.41 Million USD 21.003%
Theravance Biopharma, Inc. 45.23 Million USD 97.522%
Ultragenyx Pharmaceutical Inc. 43.16 Million USD 97.403%
Metagenomi, Inc. Common Stock 48.22 Million USD 97.676%
Lexaria Bioscience Corp. 163.96 Thousand USD -583.655%
BioCryst Pharmaceuticals, Inc. 848.71 Million USD 99.868%
UroGen Pharma Ltd. 100.21 Million USD 98.881%
Gain Therapeutics, Inc. 1.02 Million USD -9.107%
Sutro Biopharma, Inc. 182.74 Million USD 99.387%
Creative Medical Technology Holdings, Inc. 14.19 Thousand USD -7797.478%
Lisata Therapeutics, Inc. 305 Thousand USD -267.53%
Chemomab Therapeutics Ltd. 392 Thousand USD -185.96%
Stoke Therapeutics, Inc. 6.83 Million USD 83.6%
Chimerix, Inc. 2.14 Million USD 47.716%
Reneo Pharmaceuticals, Inc. 973 Thousand USD -15.207%
Outlook Therapeutics, Inc. 35.55 Million USD 96.847%
60 Degrees Pharmaceuticals, Inc. 172.67 Thousand USD -549.185%
Pluri Inc. 29.61 Million USD 96.214%
Cue Biopharma, Inc. 14.69 Million USD 92.372%
MeiraGTx Holdings plc 89.26 Million USD 98.744%
Aprea Therapeutics, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock 21.35 Thousand USD -5150.436%
Cidara Therapeutics, Inc. 4.87 Million USD 77.015%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Scholar Rock Holding Corporation 61.81 Million USD 98.187%
Sana Biotechnology, Inc. 104.09 Million USD 98.923%
Elicio Therapeutics, Inc. 6.91 Million USD 83.794%
NLS Pharmaceutics AG 1.63 Million USD 31.387%
Adlai Nortye Ltd. American Depositary Shares 31.54 Million USD 96.447%
Nutriband Inc. 241.28 Thousand USD -364.583%
Protara Therapeutics, Inc. 5.46 Million USD 79.496%
Vor Biopharma Inc. 35.66 Million USD 96.857%
Roivant Sciences Ltd. 499.74 Million USD 99.776%
ProKidney Corp. 4.41 Million USD 74.599%
Applied Therapeutics, Inc. 1.22 Million USD 8.567%
Daré Bioscience, Inc. 5.31 Million USD 78.922%
BridgeBio Pharma, Inc. 1.73 Billion USD 99.936%
Titan Pharmaceuticals, Inc. 565 Thousand USD -98.401%
Bicycle Therapeutics plc 44.95 Million USD 97.507%
Tango Therapeutics, Inc. 38.92 Million USD 97.12%
Galectin Therapeutics Inc. 71.8 Million USD 98.439%
Revolution Medicines, Inc. Warrant 87.94 Million USD 98.725%
Atai Life Sciences N.V. 16.47 Million USD 93.196%
Renovaro Biosciences Inc. 2.45 Million USD 54.265%
Aerovate Therapeutics, Inc. 675 Thousand USD -66.069%
MediciNova, Inc. 215.92 Thousand USD -419.145%
Praxis Precision Medicines, Inc. 2.49 Million USD 55.071%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 11.107%
GeoVax Labs, Inc. - USD -Infinity%
Protagonist Therapeutics, Inc. 1.14 Million USD 1.756%
Axsome Therapeutics, Inc. 186.37 Million USD 99.399%
Biomea Fusion, Inc. 10.29 Million USD 89.113%
RenovoRx, Inc. - USD -Infinity%
Erasca, Inc. 55.85 Million USD 97.993%
Cullinan Oncology, Inc. 3.59 Million USD 68.775%
NRx Pharmaceuticals, Inc. 9.16 Million USD 87.764%
4D Molecular Therapeutics, Inc. 14.67 Million USD 92.359%
Kiniksa Pharmaceuticals, Ltd. 12.25 Million USD 90.855%
bluebird bio, Inc. 330.32 Million USD 99.661%
Ventyx Biosciences, Inc. 12.5 Million USD 91.037%
Pieris Pharmaceuticals, Inc. - USD -Infinity%
Imunon, Inc. 1.62 Million USD 31.005%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 99.901%
BioAtla, Inc. 2.46 Million USD 54.432%
Allogene Therapeutics, Inc. 95.12 Million USD 98.822%
Larimar Therapeutics, Inc. 5.54 Million USD 79.788%
DBV Technologies S.A. 14.38 Million USD 92.205%
Fortress Biotech, Inc. 88.59 Million USD 98.735%
Avidity Biosciences, Inc. 9.85 Million USD 88.622%
Kezar Life Sciences, Inc. 18.93 Million USD 94.079%
aTyr Pharma, Inc. 15.09 Million USD 92.574%
Viridian Therapeutics, Inc. 21.04 Million USD 94.674%
EyeGate Pharmaceuticals, Inc. 326.49 Thousand USD -243.336%
Galecto, Inc. 249 Thousand USD -350.188%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. 1.63 Million USD 31.302%
Halozyme Therapeutics, Inc. 1.49 Billion USD 99.925%
Lexicon Pharmaceuticals, Inc. 106.06 Million USD 98.943%
Entera Bio Ltd. 390 Thousand USD -187.428%
Travere Therapeutics, Inc. 404.78 Million USD 99.723%
Sensei Biotherapeutics, Inc. 6.2 Million USD 81.943%
Xencor, Inc. 83.43 Million USD 98.656%
Orchestra BioMed Holdings, Inc. 1.68 Million USD 33.553%
Spruce Biosciences, Inc. 4.6 Million USD 75.679%
Coeptis Therapeutics Holdings, Inc. 1.22 Million USD 8.435%
Vanda Pharmaceuticals Inc. 9.4 Million USD 88.08%
Lexaria Bioscience Corp. 163.96 Thousand USD -583.655%
Portage Biotech Inc. 47 Thousand USD -2285.038%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 11.107%
Olema Pharmaceuticals, Inc. 2.41 Million USD 53.622%
OncoCyte Corporation 2.86 Million USD 60.928%
Processa Pharmaceuticals, Inc. 150.55 Thousand USD -644.562%
Purple Biotech Ltd. 351 Thousand USD -219.364%
CollPlant Biotechnologies Ltd. 3.15 Million USD 64.515%
Onconetix, Inc. 9.88 Million USD 88.661%
MacroGenics, Inc. 33.97 Million USD 96.7%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. 2.03 Million USD 44.888%
Neumora Therapeutics, Inc. Common Stock 5.23 Million USD 78.571%
Ocuphire Pharma, Inc. - USD -Infinity%
Prime Medicine, Inc. 13.63 Million USD 91.778%
Aditxt, Inc. 18.21 Million USD 93.847%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. 26.73 Million USD 95.808%
Curis, Inc. 2.79 Million USD 59.879%
Carmell Therapeutics Corporation 2.13 Million USD 47.531%
Adagene Inc. 22.3 Million USD 94.975%
Achieve Life Sciences, Inc. 16.73 Million USD 93.3%
BeiGene, Ltd. 930.18 Million USD 99.879%
Inhibrx Biosciences, Inc. 210.14 Million USD 99.467%
GlycoMimetics, Inc. 808.4 Thousand USD -38.665%
Maravai LifeSciences Holdings, Inc. 610.96 Million USD 99.817%
Protagenic Therapeutics, Inc. - USD -Infinity%
SciSparc Ltd. 76 Thousand USD -1374.958%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. 2.5 Million USD 55.197%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. 82.01 Million USD 98.633%
Fresh Tracks Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 205.91 Million USD 99.456%
Acrivon Therapeutics, Inc. Common Stock 4.64 Million USD 75.862%
Alnylam Pharmaceuticals, Inc. 2.68 Billion USD 99.958%
ADMA Biologics, Inc. 141.41 Million USD 99.207%
Rigel Pharmaceuticals, Inc. 60.57 Million USD 98.15%
Clene Inc. 32.16 Million USD 96.515%
Celldex Therapeutics, Inc. 2.54 Million USD 55.902%
Cogent Biosciences, Inc. 18.85 Million USD 94.054%
Boundless Bio, Inc. Common Stock 2.19 Million USD 48.931%
Recursion Pharmaceuticals, Inc. 50.67 Million USD 97.788%
Adicet Bio, Inc. 20.92 Million USD 94.643%
Contineum Therapeutics, Inc. Class A Common Stock 193.19 Million USD 99.42%
Absci Corporation 15.95 Million USD 92.975%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 15.3 Million USD 92.675%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 20.29 Million USD 94.476%
Surrozen, Inc. 3.37 Million USD 66.825%
Generation Bio Co. 97.89 Million USD 98.855%
Astria Therapeutics, Inc. 329 Thousand USD -240.72%
Caribou Biosciences, Inc. 27.48 Million USD 95.922%
Black Diamond Therapeutics, Inc. 25.29 Million USD 95.569%
Janux Therapeutics, Inc. 24.54 Million USD 95.432%
Invivyd, Inc. 2.16 Million USD 48.223%
Cingulate Inc. 3.13 Million USD 64.245%
Relay Therapeutics, Inc. 53.46 Million USD 97.903%
Quoin Pharmaceuticals, Ltd. 3523.73 USD -31711.972%
Tenax Therapeutics, Inc. 500.9 Thousand USD -123.789%
Spero Therapeutics, Inc. 5.54 Million USD 79.777%
Jaguar Health, Inc. 35.86 Million USD 96.874%
Artelo Biosciences, Inc. 63 Thousand USD -1679.314%
2seventy bio, Inc. 256.67 Million USD 99.563%
Clearside Biomedical, Inc. 43 Million USD 97.393%
Terns Pharmaceuticals, Inc. 603 Thousand USD -85.899%
ACADIA Pharmaceuticals Inc. 57.2 Million USD 98.04%
Capricor Therapeutics, Inc. 5.61 Million USD 80.026%
Citius Pharmaceuticals, Inc. 481.24 Thousand USD -132.931%
Relmada Therapeutics, Inc. - USD -Infinity%
Kronos Bio, Inc. 28.27 Million USD 96.035%
Innoviva, Inc. 449.07 Million USD 99.75%
Bolt Biotherapeutics, Inc. 20.21 Million USD 94.456%
Entrada Therapeutics, Inc. 68.23 Million USD 98.357%
ALX Oncology Holdings Inc. 17.19 Million USD 93.482%
Vir Biotechnology, Inc. 124.54 Million USD 99.1%
Evaxion Biotech A/S 10.86 Million USD 89.687%
Ocular Therapeutix, Inc. 83.38 Million USD 98.656%
Verve Therapeutics, Inc. 74.9 Million USD 98.504%
Tyra Biosciences, Inc. 6.49 Million USD 82.744%
Galmed Pharmaceuticals Ltd. 41 Thousand USD -2634.068%
Unity Biotechnology, Inc. 26.99 Million USD 95.847%
Connect Biopharma Holdings Limited 465 Thousand USD -141.068%
Clearmind Medicine Inc. - USD -Infinity%
AlloVir, Inc. 27.42 Million USD 95.913%
ORIC Pharmaceuticals, Inc. 10.21 Million USD 89.024%
Catalyst Pharmaceuticals, Inc. 3.55 Million USD 68.486%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 27.912%
Viking Therapeutics, Inc. 1.26 Million USD 11.034%
Keros Therapeutics, Inc. 14.44 Million USD 92.239%
SELLAS Life Sciences Group, Inc. 906 Thousand USD -23.727%
Crinetics Pharmaceuticals, Inc. 51.72 Million USD 97.833%
ImmunityBio, Inc. 883.67 Million USD 99.873%
Korro Bio, Inc. 33.2 Million USD 96.624%
C4 Therapeutics, Inc. 70.97 Million USD 98.421%
Kineta, Inc. 1.31 Million USD 14.885%
Lantern Pharma Inc. 234.47 Thousand USD -378.084%
BioVie Inc. 6.11 Million USD 81.658%
Codexis, Inc. 22.36 Million USD 94.988%
Celularity Inc. 65.41 Million USD 98.286%
Eledon Pharmaceuticals, Inc. 383 Thousand USD -192.681%
Virax Biolabs Group Limited 224.3 Thousand USD -399.763%
Kodiak Sciences Inc. 181.63 Million USD 99.383%
Cibus, Inc. 24.62 Million USD 95.447%
Annexon, Inc. 31.35 Million USD 96.425%
Assembly Biosciences, Inc. 2.34 Million USD 52.136%
Moderna, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 99.923%
Adverum Biotechnologies, Inc. 75.03 Million USD 98.506%
Avalo Therapeutics, Inc. 3.9 Million USD 71.279%
Immix Biopharma, Inc. - USD -Infinity%
Eyenovia, Inc. 16.1 Million USD 93.041%
Puma Biotechnology, Inc. 111.49 Million USD 98.995%
Monte Rosa Therapeutics, Inc. 46.03 Million USD 97.565%
Wave Life Sciences Ltd. 32.11 Million USD 96.51%
Conduit Pharmaceuticals Inc. 985 Thousand USD -13.804%
Xilio Therapeutics, Inc. 11.45 Million USD 90.216%
Alkermes plc 290.73 Million USD 99.614%
Arcellx, Inc. 97.62 Million USD 98.852%
Moolec Science SA 2.64 Million USD 57.624%
Cardiff Oncology, Inc. 2.14 Million USD 47.838%
LAVA Therapeutics N.V. 6.31 Million USD 82.243%
Enanta Pharmaceuticals, Inc. 26.51 Million USD 95.772%
Regulus Therapeutics Inc. 3.1 Million USD 63.863%
Atea Pharmaceuticals, Inc. 2.4 Million USD 53.332%
Compass Therapeutics, Inc. 1.73 Million USD 35.316%
Greenwich LifeSciences, Inc. - USD -Infinity%
Humacyte, Inc. 58.1 Million USD 98.071%
Acumen Pharmaceuticals, Inc. 28.48 Million USD 96.065%
Geron Corporation 85.89 Million USD 98.695%
Verrica Pharmaceuticals Inc. 45.51 Million USD 97.537%
Avenue Therapeutics, Inc. - USD -Infinity%
Royalty Pharma plc 6.13 Billion USD 99.982%
TFF Pharmaceuticals, Inc. 115.25 Thousand USD -872.607%
Notable Labs, Ltd. 2.04 Million USD 45.292%
Mersana Therapeutics, Inc. 33.83 Million USD 96.686%
Structure Therapeutics Inc. 5.45 Million USD 79.443%
IN8bio, Inc. 4.89 Million USD 77.09%
89bio, Inc. 27.1 Million USD 95.865%
DiaMedica Therapeutics Inc. 400 Thousand USD -180.242%
Vera Therapeutics, Inc. 53.7 Million USD 97.913%
Acasti Pharma Inc. - USD -Infinity%
Genelux Corporation 2.51 Million USD 55.499%
Trevi Therapeutics, Inc. 1.33 Million USD 16.221%
Liquidia Corporation 3.5 Million USD 68.0%
Mustang Bio, Inc. 2.49 Million USD 55.125%
Immunovant, Inc. 138 Thousand USD -712.296%
Vericel Corporation 88.14 Million USD 98.728%
Quantum-Si incorporated 15.3 Million USD 92.675%
Arbutus Biopharma Corporation 8.72 Million USD 87.146%
XOMA Corporation 124.45 Million USD 99.099%
ARS Pharmaceuticals, Inc. 274 Thousand USD -309.112%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. 81.68 Thousand USD -1272.39%
Alpha Tau Medical Ltd. 13.27 Million USD 91.556%
Vaxcyte, Inc. 29.22 Million USD 96.164%
Xenon Pharmaceuticals Inc. 10.9 Million USD 89.719%
Estrella Immunopharma, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. 203 Thousand USD -452.201%
Tempest Therapeutics, Inc. 20.66 Million USD 94.574%
Sol-Gel Technologies Ltd. 1.65 Million USD 32.186%
Rhythm Pharmaceuticals, Inc. 1.26 Million USD 11.034%
Soleno Therapeutics, Inc. 403 Thousand USD -178.156%
Enlivex Therapeutics Ltd. 1.03 Million USD -8.621%
PepGen Inc. 20.1 Million USD 94.424%
Moleculin Biotech, Inc. 574 Thousand USD -95.291%
United Therapeutics Corporation 700 Million USD 99.84%
Solid Biosciences Inc. 26.26 Million USD 95.732%
BriaCell Therapeutics Corp. - USD -Infinity%
Conduit Pharmaceuticals Inc. 985 Thousand USD -13.804%
Immuneering Corporation 4.46 Million USD 74.883%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. - USD -Infinity%
Telomir Pharmaceuticals, Inc. Common Stock 101 Thousand USD -1009.869%
Belite Bio, Inc 886 Thousand USD -26.52%
Pharming Group N.V. 171.54 Million USD 99.347%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited 239.61 Million USD 99.532%
Pyxis Oncology, Inc. 21.33 Million USD 94.745%
uniQure N.V. 138.4 Million USD 99.19%
Windtree Therapeutics, Inc. 16.83 Million USD 93.339%
GeoVax Labs, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 85.42 Million USD 98.688%
Altimmune, Inc. 671 Thousand USD -67.059%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. 13.27 Million USD 91.556%
Peak Bio, Inc. 10.72 Million USD 89.545%
SeaStar Medical Holding Corporation 9.08 Million USD 87.656%
FibroBiologics, Inc. Common Stock 1.74 Million USD 35.835%
Benitec Biopharma Inc. 284 Thousand USD -294.707%
Zura Bio Limited - USD -Infinity%
Amicus Therapeutics, Inc. 445.05 Million USD 99.748%
Salarius Pharmaceuticals, Inc. 289.64 Thousand USD -287.017%
Compugen Ltd. 1.35 Million USD 17.027%
Elevai Labs, Inc. Common Stock 210.48 Thousand USD -432.554%
argenx SE 20 Million USD 94.395%
Zevra Therapeutics, Inc. 42.76 Million USD 97.379%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 84.55 Million USD 98.674%
NKGen Biotech, Inc. Common Stock 19.92 Million USD 94.373%
Madrigal Pharmaceuticals, Inc. 117.19 Million USD 99.043%
PolyPid Ltd. 11.77 Million USD 90.483%
Aileron Therapeutics, Inc. 91.45 Million USD 98.774%
Plus Therapeutics, Inc. 4.18 Million USD 73.189%
Forte Biosciences, Inc. - USD -Infinity%
Dianthus Therapeutics, Inc. 585 Thousand USD -91.618%
Instil Bio, Inc. 86.05 Million USD 98.697%
Elevation Oncology, Inc. 30.13 Million USD 96.28%
Immunome, Inc. 1.65 Million USD 32.063%
Verona Pharma plc 51.32 Million USD 97.816%
Enveric Biosciences, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants 9.77 Million USD 88.536%
Shattuck Labs, Inc. 4.2 Million USD 73.323%
LENZ Therapeutics, Inc. 362 Thousand USD -209.66%
Design Therapeutics, Inc. 3.05 Million USD 63.247%
Leap Therapeutics, Inc. 262 Thousand USD -327.85%
Seelos Therapeutics, Inc. 14.22 Million USD 92.121%
Achilles Therapeutics plc 4.61 Million USD 75.71%
Fractyl Health, Inc. Common Stock 373.72 Million USD 99.7%
Rani Therapeutics Holdings, Inc. 30.09 Million USD 96.276%
MoonLake Immunotherapeutics 3.69 Million USD 69.686%
Beam Therapeutics Inc. 173.17 Million USD 99.353%
Moolec Science SA 2.64 Million USD 57.624%
Longboard Pharmaceuticals, Inc. 475 Thousand USD -135.993%
AEON Biopharma, Inc. 278 Thousand USD -303.226%
Aadi Bioscience, Inc. 7.02 Million USD 84.041%
Enliven Therapeutics, Inc. 335 Thousand USD -234.617%
Iovance Biotherapeutics, Inc. 75.86 Million USD 98.522%
Taysha Gene Therapies, Inc. 61.1 Million USD 98.166%
Inovio Pharmaceuticals, Inc. 30.2 Million USD 96.289%
Athira Pharma, Inc. 1.58 Million USD 29.276%
HCW Biologics Inc. 6.45 Million USD 82.625%
XOMA Corporation 124.45 Million USD 99.099%
NeurAxis, Inc. 224.26 Thousand USD -399.852%
Lumos Pharma, Inc. 6.58 Million USD 82.977%
enGene Holdings Inc. Common Stock 9.77 Million USD 88.536%
180 Life Sciences Corp. 1.32 Million USD 15.083%
Nektar Therapeutics 230.4 Million USD 99.513%
NKGen Biotech, Inc. Warrants 19.92 Million USD 94.373%
Opiant Pharmaceuticals, Inc. 17.08 Million USD 93.437%
Arvinas, Inc. 3.4 Million USD 67.03%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 27.912%
Palisade Bio, Inc. 369 Thousand USD -203.785%
Nutriband Inc. 241.28 Thousand USD -364.583%
Tevogen Bio Holdings Inc. 1.63 Million USD 31.302%
CG Oncology, Inc. Common stock 826 Thousand USD -35.71%
Tourmaline Bio, Inc. 415 Thousand USD -170.113%
Merus N.V. 12.16 Million USD 90.783%
Omega Therapeutics, Inc. 128.42 Million USD 99.127%
Neurogene Inc. 16.25 Million USD 93.104%
Mirum Pharmaceuticals, Inc. 308.14 Million USD 99.636%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock 28.54 Million USD 96.072%
Sesen Bio, Inc. - USD -Infinity%
Quince Therapeutics, Inc. 13.81 Million USD 91.885%
Rezolute, Inc. 2.22 Million USD 49.687%
Clene Inc. 32.16 Million USD 96.515%
Indaptus Therapeutics, Inc. 175.05 Thousand USD -540.359%
BeyondSpring Inc. 3.99 Million USD 71.941%
Synlogic, Inc. 17.27 Million USD 93.511%
Allarity Therapeutics, Inc. 1.3 Million USD 13.772%
Phio Pharmaceuticals Corp. 35 Thousand USD -3102.766%
Peak Bio, Inc. 10.72 Million USD 89.545%
Werewolf Therapeutics, Inc. 51.92 Million USD 97.841%
Krystal Biotech, Inc. 8.09 Million USD 86.151%
Karyopharm Therapeutics Inc. 177.01 Million USD 99.367%
SpringWorks Therapeutics, Inc. 7.05 Million USD 84.116%
Lipella Pharmaceuticals Inc. 136.59 Thousand USD -720.657%
MannKind Corporation 382.37 Million USD 99.707%
Ikena Oncology, Inc. 10.73 Million USD 89.561%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 409 Thousand USD -174.075%
Gossamer Bio, Inc. 212.46 Million USD 99.472%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. 174 Thousand USD -544.234%
NRx Pharmaceuticals, Inc. 9.16 Million USD 87.764%
Legend Biotech Corporation 328.67 Million USD 99.659%
Mural Oncology plc 15 Million USD 92.531%
Disc Medicine, Inc. 2.1 Million USD 46.646%
Champions Oncology, Inc. 7.43 Million USD 84.913%
REGENXBIO Inc. 89.29 Million USD 98.745%
Ensysce Biosciences, Inc. 854.69 Thousand USD -31.154%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. 552.98 Thousand USD -102.713%
Edgewise Therapeutics, Inc. 5.41 Million USD 79.295%
Vaxart, Inc. 26.51 Million USD 95.772%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. 15.65 Million USD 92.841%
Cellectis S.A. 92.85 Million USD 98.793%
Longeveron Inc. 2.04 Million USD 45.078%
Repare Therapeutics Inc. 3.41 Million USD 67.127%
Sarepta Therapeutics, Inc. 1.39 Billion USD 99.92%
Inozyme Pharma, Inc. 46.59 Million USD 97.594%
Revolution Medicines, Inc. 87.94 Million USD 98.725%
Nymox Pharmaceutical Corporation 173 Thousand USD -547.958%
Third Harmonic Bio, Inc. 3.95 Million USD 71.643%
ArriVent BioPharma, Inc. Common Stock 317 Thousand USD -253.618%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 175 Thousand USD -540.553%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 99.861%
Denali Therapeutics Inc. 52.24 Million USD 97.854%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 14.4 Million USD 92.218%
Corvus Pharmaceuticals, Inc. 1.37 Million USD 18.416%
Cingulate Inc. 3.13 Million USD 64.245%
Passage Bio, Inc. 26.29 Million USD 95.737%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. 6.66 Million USD 83.181%
Day One Biopharmaceuticals, Inc. 408 Thousand USD -174.747%
Oramed Pharmaceuticals Inc. 894 Thousand USD -25.388%
Scinai Immunotherapeutics Ltd. 20.56 Million USD 94.548%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 2.45 Million USD 54.267%
Carisma Therapeutics, Inc. 3.12 Million USD 64.106%
Unicycive Therapeutics, Inc. 811 Thousand USD -38.22%
OmniAb, Inc. 25.56 Million USD 95.615%
Anew Medical, Inc. 1.6 Million USD 30.158%
Fennec Pharmaceuticals Inc. 29.58 Million USD 96.211%
Lipocine Inc. 17.16 Thousand USD -6430.164%
Lexeo Therapeutics, Inc. Common Stock 11.63 Million USD 90.368%
Nautilus Biotechnology, Inc. 34.62 Million USD 96.763%
SAB Biotherapeutics, Inc. 5.9 Million USD 81.023%
G1 Therapeutics, Inc. 57.17 Million USD 98.039%
Bellerophon Therapeutics, Inc. 203 Thousand USD -452.201%
Sage Therapeutics, Inc. 5.16 Million USD 78.297%
Ocugen, Inc. 6.94 Million USD 83.85%
Mind Medicine (MindMed) Inc. 14.12 Million USD 92.066%
Q32 Bio Inc. 1.31 Million USD 14.949%
Brainstorm Cell Therapeutics Inc. 672 Thousand USD -66.811%
Alumis Inc. Common Stock 32.58 Million USD 96.559%
Equillium, Inc. 824 Thousand USD -36.04%
Kyverna Therapeutics, Inc. 9.07 Million USD 87.653%
Coya Therapeutics, Inc. - USD -Infinity%
CNS Pharmaceuticals, Inc. 300.8 Thousand USD -272.655%
Dominari Holdings Inc. 3.02 Million USD 62.98%
Edesa Biotech, Inc. 94.48 Thousand USD -1086.373%
vTv Therapeutics Inc. 529 Thousand USD -111.903%
Bio-Techne Corporation 419.53 Million USD 99.733%
Agios Pharmaceuticals, Inc. 71.99 Million USD 98.443%
Harmony Biosciences Holdings, Inc. 193.56 Million USD 99.421%
Prelude Therapeutics Incorporated 16.88 Million USD 93.362%
Candel Therapeutics, Inc. 22.76 Million USD 95.075%
iTeos Therapeutics, Inc. 6.05 Million USD 81.496%
Nkarta, Inc. 88.33 Million USD 98.731%
BioCardia, Inc. 1.31 Million USD 14.755%
Iterum Therapeutics plc 19.5 Million USD 94.254%